$Pistol Pete$, $Mick$ & Friends Stock Picks /news, DD and charts

[NWriter]

$RGC, a Potential Defensive Company Stock

Regencell Bioscience Holdings (RGC)'s CEO (Mr. Yat-Gai Au) has been buying RGC shares since 2021 at an average price of $26 a share — and now has over 80% ownership.

The company had a huge upward swing days after the IPO but was hit with short sellers following that. Even at volatile times, the company CEO has not sold a single share and its even backed by prominent investor Samuel Chen as one of the company's major backers.

(For context : Samuel Chen was a successful early Zoom Video Communications (Nasdaq: ZM) investor)

Despite being shorted heavily in the early months of Q2 22', the company stock has been on an upward trent despite the huge sell off in many markets sectors, predominantly in the growth stock and crypto market.

RGC could be a play by investors who wishes to diversify their porfolio into healthcare stock to reduce the downside risk of market volatility. RGC is still in their early stage of TMC trial and we look forward to positive results from their R&D for ADHD & ASD treatments.

[https://www.benzinga.com/general/biotech/22/06/27567868/traders-may-keep-hunting-for-another-squeezable-stock-like-gamestop-how-does-this-tickers-short-i]